Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects

被引:19
|
作者
Ahmed, Radwan H. [1 ]
Huri, Hasniza Zaman [2 ,3 ]
Al-Hamodi, Zaid [4 ]
Salem, Sameer D. [4 ]
Al-absi, Boshra [1 ]
Muniandy, Sekaran [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia
[3] Univ Malaya Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia
[4] Sanaa Univ, Dept Biochem & Mol Biol, Fac Med, Sanaa, Yemen
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
DIPEPTIDYL-PEPTIDASE-IV; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; LINKING OBESITY; DISEASE; INFLAMMATION; INHIBITOR;
D O I
10.1371/journal.pone.0154369
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Genetic polymorphisms of the Dipeptidyl Peptidase 4 (DPP4) gene may play a role in the etiology of type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association of single nucleotide polymorphisms (SNPs) of the DPP4 gene in Malaysian subjects with T2DM and evaluated whether they had an effect on the serum levels of soluble dipeptidyl peptidase 4 (sDPP-IV). Method Ten DPP4 SNPs were genotyped by TaqMan genotyping assays in 314 subjects with T2DM and 235 controls. Of these, 71 metabolic syndrome (MetS) subjects were excluded from subsequent analysis. The odds ratios (ORs) and their 95% confidence interval (CIs) were calculated using multiple logistic regression for the association between the SNPs of DPP4 and T2DM. In addition, the serum levels of sDPP-IV were investigated to evaluate the association of the SNPs of DPP4 with the sDPP-IV levels. Results Dominant, recessive, and additive genetic models were employed to test the association of DPP4 polymorphisms with T2DM, after adjusting for age, race, gender and BMI. The rs12617656 was associated with T2DM in Malaysian subjects in the recessive genetic model (OR = 1.98, p = 0.006), dominant model (OR = 1.95, p = 0.008), and additive model (OR = 1.63, p = 0.001). This association was more pronounced among Malaysian Indians, recessive (OR = 3.21, p = 0.019), dominant OR = 3.72, p = 0.003) and additive model (OR = 2.29, p = 0.0009). The additive genetic model showed that DPP4 rs4664443 and rs7633162 polymorphisms were associated with T2DM (OR = 1.53, p = 0.039), and (OR = 1.42, p = 0.020), respectively. In addition, the rs4664443 G>A polymorphism was associated with increased sDPP-IV levels (p = 0.042) in T2DM subjects. Conclusions DPP4 polymorphisms were associated with T2DM in Malaysian subjects, and linked to variations in sDPP-IV levels. In addition, these associations were more pronounced among Malaysian Indian subjects.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals
    Xing, Xiaomin
    Han, Yi
    Zhou, Xiaojun
    Zhang, Bo
    Li, Yan
    Wang, Zhongsu
    Liao, Lin
    Su, Lequn
    NEUROPEPTIDES, 2016, 60 : 1 - 6
  • [2] Association of the clusterin gene polymorphisms with type 2 diabetes mellitus
    Daimon, Makoto
    Oizumi, Toshihide
    Karasawa, Shigeru
    Kaino, Wataru
    Takase, Kaoru
    Tada, Kyouko
    Jimbu, Yumi
    Wada, Kiriko
    Kameda, Wataru
    Susa, Shinji
    Muramatsu, Masaaki
    Kubota, Isao
    Kawata, Sumio
    Kato, Takeo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (06): : 815 - 822
  • [3] DPP4 in diabetes
    Roehrborn, Diana
    Wronkowitz, Nina
    Eckel, Juergen
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 20
  • [4] Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus
    Yamaguchi, Sachiyo
    Yamada, Yoshiji
    Matsuo, Hitoshi
    Segawa, Tomonori
    Watanabe, Sachiro
    Kato, Kimihiko
    Yokoi, Kiyoshi
    Ichihara, Sahoko
    Metoki, Norifumi
    Yoshida, Hidemi
    Satoh, Kei
    Nozawa, Yoshinori
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (04) : 631 - 637
  • [5] ASSOCIATION OF CTLA-4 GENE POLYMORPHISMS IN TAIWANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Shiau, M. Y.
    Hsiao, C. W.
    Shih, Y. L.
    Huang, C. N.
    Chang, Y. H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A129 - A130
  • [6] Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
    Saito, Tatsuhiko
    Ohnuma, Kei
    Suzuki, Hiroshi
    Dang, Nam H.
    Hatano, Ryou
    Ninomiya, Hiroki
    Morimoto, Chikao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : E8 - E12
  • [7] SGLT2 versus DPP4 inhibitors for type 2 diabetes
    Scheen, Andre J.
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (03): : 168 - 170
  • [8] Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus
    Ali, Soham
    Fortune, Kathryn
    Masur, Jack
    Viscuse, Paul Vincent
    Devitt, Michael Edward
    Dreicer, Robert
    Skelton IV, William Paul
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [9] COST-UTILITY OF DAPAGLIFLOZIN VERSUS DPP4 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COLOMBIA
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A172 - A172
  • [10] Association of beta 2 adrenoceptor gene polymorphisms in Malaysian hypertensive subjects
    Komara, M.
    Vasudevan, R.
    Ismail, P.
    Bakar, S. A.
    Pishva, S. R.
    Heidari, F.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 2939 - 2948